Clinical application of right ventricular defibrillator leads with floating atrial sensing bipolar electrodes

Hai-bo YU,Yan-chun LIANG,Guo-qing XU,Bai-ge XU,Zu-lu WANG,Ya-ling HAN

DOI: https://doi.org/10.16680/j.1671-3826.2016.07.01

2016-01-01

Abstract:Objective The study was performed to evaluate the clinical effect and safety of ventricular defibrillator lead(A + ICD lead)with floating atrial sensing bipolar electrodes in patients with implantable cardioverter defibrillator(ICD). Methods Totally 28 patients were implanted ICD(Biotronik Germany Lumax 540 VR-T DX)with A + ICD lead(Linox Smart SDX65). Long-term right atri-al sensing,right ventricular threshold,lead impedance,sensing parameters were collected by home monitoring(HM)system and ana-lyzed. Clinical follow-up was performed at 3 months after intervention,atrial sensing changes were observed in supine,sitting and stand-ing position;and how atrial intracardiac electrocardiogram works in a single chamber implantable cardioverter defibrillator was ob-served. Results All 28 patients were implanted successfully,and the mean follow-up periods were(704. 57 ± 308. 73)days. No signif-icant changes were found in atrial sensing,ventricular sensing,threshold,as well as impedance before discharge,one month,three months,six months,and 12 months after intervention. Three months after 28 patients' intervention,no significant changes in atrial sens-ing were found while patients were in supine or sitting or standing position. Atrial sensing helped early identify and manage atrial ar-rhythmias,facilitate differential diagnosis of superventricular tachycardia and ventricular tachycardia,and optimize atrioventricular se-quential pacing. Conclusion A + ICD lead could provide stable long-term atrial and ventricular lead parameters. A + ICD lead could help acquire stable atrial sensing,which leads to atrioventricular sequential pacing,and early identification and management of atrial arrhythmias.